ImmuPharma (LON:IMM) Share Price Crosses Below 200-Day Moving Average of $2.38

ImmuPharma plc (LON:IMMGet Free Report)’s share price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 2.38 ($0.03) and traded as low as GBX 1.61 ($0.02). ImmuPharma shares last traded at GBX 1.68 ($0.02), with a volume of 575,324 shares.

ImmuPharma Price Performance

The business has a fifty day simple moving average of GBX 1.86 and a two-hundred day simple moving average of GBX 2.38. The company has a market cap of £6.70 million, a PE ratio of -168.25 and a beta of 1.38.

About ImmuPharma

(Get Free Report)

ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.

Featured Articles

Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with's FREE daily email newsletter.